Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Reading the future of the European labs sector

The European diagnostic lab sector in 2016 presents opportunities, but also substantial threats. Apart from seizing market share from competitors, there are four ways that labs can grow sales – consolidation/rationalisation, diversification into new test groups, outsourcing and finally moving into other areas - be that imaging or outpatient specialty care.

Thyrocare’s five-year plan to quadruple sales

Mumbai-listed lab group Thyrocare has presented a five-year expansion plan that should take the company from 7 to 25 labs and from 1,200 to 5,000 service franchises by 2020. According to targets, sales will be up 20% to Rs300cr (US$45m) in 2016 and should hit Rs1,000cr (US$150m) by 2020.

Sonic Healthcare buys German lab network Staber for €120m

Australian diagnostics network Sonic Healthcare has bought Munich-based laboratory group Staber for €120m. The move allows Sonic to expand its footprint in Germany and is a significant step in the group's growth strategy, according to one consultant.

Alliar breaks Brazil’s IPO drought

Brazil's third largest lab group Alliar floated on Friday 28 October at R$20 per share. This raises roughly US$88m in cash for its buy-and-build in southern Brazil. Investors celebrate the accomplishment as it puts an end to a yearlong IPO drought in Sao Paulo amidst recession.

Eurofins fails to raise debt

Pan-European testing network Eurofins has failed to raise debt according to several sources. It is widely understood that the group wants to conduct a large acquisition soon.

Unilabs set to sell for €1.5bn within weeks

Sources close to the Western European diagnostics chain say JP Morgan and Goldman Sachs are in the process of raising the money to allow Synlabs to buy Unilabs in a deal valued at €1.5bn. And what about French reference lab Cerba, which PAI plans to sell before Christmas?

Austerity bites in Abu Dhabi

Gulf states are targeting waste in their health systems as the low oil price places government budgets under strain. Co-payments, quotas and VAT may become commonplace in an industry not previously known for having to make economies, and the damage is already showing on operators.

NHS trusts still reluctant to outsource tests

NHS trusts in the UK are still avoiding outsourcing tests to private labs, despite the private sector demonstrating greater efficiency, says a consultant who has been working closely with both.

Find Us